Nutrigenomics Market Size Worth USD 1,289.7 Million in 2028 at a CAGR of 16.2%
According to the most recent report by Emergen Research, the size of the worldwide nutrigenomics market is anticipated to reach USD 1,289.7 Million in 2028 and record a consistent revenue CAGR throughout the projected period. The rising global burden of non-communicable diseases linked to poor nutrition is the main driver of market revenue growth. Through the creation of more durable strategies to promote dietary change at a population-level, nutrigenomics is anticipated to lessen the burden of nutrition-related non-communicable diseases. The formation of organisations like the European Nutrigenomics Organizations (NUGO) and the International Society for Nutrigenomics & Nutrigenetics has led to an increase in nutrigenomics-related research and development efforts. Growth in the field of nutrigenomics is anticipated to be supported by developments in technology that assist in processing enormous data volumes related to gene variants.
The field of science known as nutrigenomics studies how our foods impact the way our genes work. It focuses on how the body’s response to various nutrients is influenced by genetic variations. Nutrigenomic analysis aids in locating and assessing numerous genetic markers. The test also assists in identifying certain metabolic weak points, hence preventing diseases linked to nutrition. However, obstacles like the high prices of nutrigenomic testing, growing worries about the security of one’s genetic information, and a shortage of qualified healthcare practitioners are projected to to some extent impede market revenue growth.
Claim Your FREE Sample Copy with Table of [email protected] https://www.emergenresearch.com/request-sample/787
Some major companies operating in the market include Koninklijke DSM N.V., BASF SE, Danone S.A., Unilever plc, Genova Diagnostics, Nutrigenomix Inc., Metagenics, Inc., GX Sciences Inc., Cell-Logic, and Xcode Life.
Some Key Highlights from the Report:
- In 2020, the obesity segment accounted for the biggest revenue share. During the projected period, it is anticipated that rising obesity rates among the expanding population brought on by sedentary lifestyles and eating patterns will spur market expansion.
- During the projected period, revenue from the reagents and kits sector is anticipated to grow at a quick CAGR. Demand for nutrigenomic testing kits is anticipated to increase due to a shift in consumer preferences toward personalised nutrition, which will enable people to receive a customised diet based on their genetic, phenotypic, and medical information.
- In terms of revenue, North America contributed the most to the worldwide nutrigenomics market in 2020. Increasing nutrigenomics-related research and development efforts are anticipated to fuel market expansion in the area throughout the forecast period.
To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/nutrigenomics-market
For the purpose of this report, Emergen Research has segmented the global nutrigenomics market on the basis of application, product, and region:
Application Outlook (Revenue, USD Million; 2018–2028)
- Cardiovascular Diseases
- Cancer Research
Product Outlook (Revenue, USD Million; 2018–2028)
- Reagents and Kits
Regional Outlook (Revenue, USD Million; 2018–2028)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights